AOAC SPSFAM Meeting Book 9-24

FOR IMMEDIATE RELEASE 9/13/2017 CONTACT: Dawn Frazier  Executive for Scientific Business Development  AOAC INTERNATIONAL   dfrazier@aoac.org www.aoac.org

AOAC To Launch Working Group to Develop Standards for Veterinary Drug Residues 

Rockville, MD: AOAC is partnering with Thermo Scientific , Nestlé , Fonterra , Abbott Nutrition , and Tyson Foods  to develop  Standard Method Performance Requirements  (SMPRs ® ) for a wide variety of veterinary drug residues in selected matrices. A  working group, chaired by  Joe Boison of the Canadian Food Inspection Agency, will begin standards development activities for  the project on September 24, 2017, during the 131st AOAC Annual Meeting and Exposition in Atlanta, Georgia, USA. The project  will be part of the AOAC Stakeholder Panel on Strategic Food Analytical Methods (SPSFAM) activities.   “Incorrect use of veterinary drugs in animal production has led to residues in various edible animal tissues, and microbial  resistance is a major concern for public health,” Boison said. “Standards and methods are needed for analysis of veterinary  drugs in food to ensure that regulatory requirements are met, and, ultimately, to protect consumers and facilitate global  trade.”   Organizations such as Codex Alimentarius, European Commission, and the U.S. Food and Drug Administration have established  maximum residue limits (MRLs)/tolerances for many veterinary medicinal products in foodstuffs from animal origin, while  banned/prohibited from use in food animal production.   AOAC’s partners who compose an advisory panel for the project agree that a qualitative method or suite of methods are  needed for the control of compliance (QC) to support product release in manufacturing. The advisory panel proposes that the  working group develop a series of SMPRs for methods applicable to the analysis of veterinary drugs (antibiotics, antiparasitics,  anti‐inflammatories, and tranquilizers) in raw milk; processed dairy powder ingredients (full‐cream milk, fat‐filled milk,  skimmed milk, whey proteins, lactose, and caseinate); meat (chicken, duck, turkey, beef, pork, lamb, and veal); fish (salmon and  anchovy); seafood (shrimp); egg powders (whole, white, and yolk); and infant formulae (regular and hydrolyzed). The  method(s), based on liquid chromatography‐mass spectrometry, should be able to check the compliance with regard to  worldwide regulatory limits.   During the AOAC Annual Meeting, the Working Group on Veterinary Drug Residues will examine the background, technical  issues and needs, analytical challenges, regulatory requirements, and gaps in current methodology, etc. in developing a fitness‐ for‐purpose statement based on the advisory panel’s priorities. The fitness‐for‐purpose statement will be reviewed for possible  endorsement by SPSFAM, chaired by Erik Konings of Nestlé Research Center .  Based on endorsed fitness‐for‐purpose, the working group will then begin developing the first in a series of draft SMPRs for  methods capable of measuring a wide variety of veterinary drugs in selected matrices.  

To participate on the AOAC SPSFAM Working Group on Veterinary Drug Residues, visit https://goo.gl/T8WzAU  to sign up.  

AOAC INTERNATIONAL is a globally recognized, 501(c)(3), independent, third party, not‐for‐profit association and voluntary  consensus standards developing organization founded in 1884. When analytical needs arise within a community or industry,  AOAC INTERNATIONAL is the forum for finding appropriate science‐based solutions through the development of microbiological  and chemical standards. AOAC standards are used globally to promote trade and to facilitate public health and safety.